Literature DB >> 33757984

Covid-19: variants and vaccination.

Alistair C Darby1,2, Julian A Hiscox3,4,5.   

Abstract

Entities:  

Year:  2021        PMID： 33757984     DOI： 10.1136/bmj.n771

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation.

Authors:  Rachel E Lamerton; Edith Marcial-Juarez; Sian E Faustini; Marisol Perez-Toledo; Margaret Goodall; Siân E Jossi; Maddy L Newby; Iain Chapple; Thomas Dietrich; Tonny Veenith; Adrian M Shields; Lorraine Harper; Ian R Henderson; Julie Rayes; David C Wraith; Steve P Watson; Max Crispin; Mark T Drayson; Alex G Richter; Adam F Cunningham
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Authors:  Tobias Moll; Valerie Odon; Calum Harvey; Mark O Collins; Andrew Peden; John Franklin; Emily Graves; Jack Ng Marshall; Cleide Dos Santos Souza; Sai Zhang; Lydia Castelli; Guillaume Hautbergue; Mimoun Azzouz; David Gordon; Nevan Krogan; Laura Ferraiuolo; Michael P Snyder; Pamela J Shaw; Jan Rehwinkel; Johnathan Cooper-Knock
Journal:  Life Sci Alliance       Date:  2022-10-14

3.  Mathematical modeling of the impact of Omicron variant on the COVID-19 situation in South Korea.

Authors:  Jooha Oh; Catherine Apio; Taesung Park
Journal:  Genomics Inform       Date:  2022-06-22

4.  Machine Learning Models to Predict In-Hospital Mortality among Inpatients with COVID-19: Underestimation and Overestimation Bias Analysis in Subgroup Populations.

Authors:  Javad Zarei; Amir Jamshidnezhad; Maryam Haddadzadeh Shoushtari; Ali Mohammad Hadianfard; Maria Cheraghi; Abbas Sheikhtaheri
Journal:  J Healthc Eng       Date:  2022-06-23       Impact factor: 3.822

5.  Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.

Authors:  Anton Pottegård; Lars Christian Lund; Øystein Karlstad; Jesper Dahl; Morten Andersen; Jesper Hallas; Øjvind Lidegaard; German Tapia; Hanne Løvdal Gulseth; Paz Lopez-Doriga Ruiz; Sara Viksmoen Watle; Anders Pretzmann Mikkelsen; Lars Pedersen; Henrik Toft Sørensen; Reimar Wernich Thomsen; Anders Hviid
Journal:  BMJ       Date:  2021-05-05

Review 6.  Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.

Authors:  Aneta Aleksova; Giulia Gagno; Gianfranco Sinagra; Antonio Paolo Beltrami; Milijana Janjusevic; Giuseppe Ippolito; Alimuddin Zumla; Alessandra Lucia Fluca; Federico Ferro
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Image and structured data analysis for prognostication of health outcomes in patients presenting to the ED during the COVID-19 pandemic.

Authors:  Liam Butler; Ibrahim Karabayir; Mohammad Samie Tootooni; Majid Afshar; Ari Goldberg; Oguz Akbilgic
Journal:  Int J Med Inform       Date:  2021-12-09       Impact factor: 4.730

8.  Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.

Authors:  Michael I Barton; Stuart A MacGowan; Mikhail A Kutuzov; Omer Dushek; Geoffrey John Barton; P Anton van der Merwe
Journal:  Elife       Date:  2021-08-26       Impact factor: 8.140

Review 9.  SARS-CoV-2 variants and environmental effects of lockdowns, masks and vaccination: a review.

Authors:  Shirin Akter; Marzuka Ahmed Zakia; M Mofijur; Shams Forruque Ahmed; Dai-Viet N Vo; Gulam Khandaker; T M I Mahlia
Journal:  Environ Chem Lett       Date:  2021-09-26       Impact factor: 13.615

10.  Challenges in Establishing Vaccine Induced Herd Immunity through Age Specific Community Vaccinations.

Authors:  Barsha Dassarma; Satyajit Tripathy; Matimbha Chabalala; Motlalepula Gilbert Matsabisa
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.